Contact
searchSearch
HMP Global

Respiratory Syncytial Virus

Featured Article

News
Long-Term Effectiveness of RSV Vaccine Declines Over Two Seasons, VHA Study Finds
11/25/2025
Grace Taylor, MS, MA
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health...
11/25/2025
Pharmacy Learning Network
News
RSV Vaccination Rates Remain Low Among US Veterans
11/19/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus...
11/19/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Shows Strong Safety Profile in Adults, Global Analysis Finds
11/14/2025
Grace Taylor, MS, MA
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds...
11/14/2025
Pharmacy Learning Network
News
Primary Care Providers Drive RSV Vaccine Uptake Among Older Adults
11/12/2025
Grace Taylor, MS, MA
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey...
11/12/2025
Pharmacy Learning Network
News
RSV Poses Significant Threat to Patients With Systemic Autoimmune Rheumatic Diseases
10/31/2025
Grace Taylor, MS, MA
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune...
10/31/2025
Pharmacy Learning Network
News
Dual RSV and Influenza Vaccination Reduces Health Care Utilization and Costs Among Older Adults
10/31/2025
Juliet Gallagher
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study...
10/31/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Proves Highly Effective Against Severe RSV in Older Adults
10/29/2025
Grace Taylor, MS, MA
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser...
10/29/2025
Pharmacy Learning Network
News
RSV Poses Sixfold Higher Hospitalization and Death Risk for Long-Term Care Residents
10/21/2025
Lisa Kuhns, PhD, MD
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term...
10/21/2025
Pharmacy Learning Network
News
RSV Vaccines Cut Hospitalizations in Older Adults but Show Gaps in High-Risk Groups
09/29/2025
Grace Taylor, MS, MA
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds...
09/29/2025
Pharmacy Learning Network
News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
News
Comorbidities Drive ICU Admission and Mortality in RSV and HMPV Among Older Adults
07/16/2025
Grace Taylor, MS, MA
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals distinct comorbidity-driven risks for ICU admission and mortality in older adults hospitalized with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV).]
A Colorado study reveals...
07/16/2025
Pharmacy Learning Network

Newsfeed

News
Long-Term Effectiveness of RSV Vaccine Declines Over Two Seasons, VHA Study Finds
11/25/2025
Grace Taylor, MS, MA
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health Administration (VHA) study shows that respiratory syncytial virus (RSV) vaccine protection in older adults remains strong initially but declines substantially over 18 months, especially among immunocompromised...
A large US Veterans Health...
11/25/2025
Pharmacy Learning Network
News
RSV Vaccination Rates Remain Low Among US Veterans
11/19/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus (RSV) vaccination rates among US veterans remain low, exposing persistent gaps in preventive care despite widespread eligibility and no-cost access through the Veterans Health Administration (VHA), according to a...
Respiratory syncytial virus...
11/19/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Shows Strong Safety Profile in Adults, Global Analysis Finds
11/14/2025
Grace Taylor, MS, MA
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds bivalent RSVpreF vaccine safe and well tolerated in adults, reinforcing its role in protecting against respiratory syncytial virus infection.
A large global analysis finds...
11/14/2025
Pharmacy Learning Network
News
Primary Care Providers Drive RSV Vaccine Uptake Among Older Adults
11/12/2025
Grace Taylor, MS, MA
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey study reveals that primary care providers are the leading influence driving older adults to receive the respiratory syncytial virus (RSV) vaccine, highlighting a key opportunity for pharmacists to boost...
A prospective multisite survey...
11/12/2025
Pharmacy Learning Network
News
RSV Poses Significant Threat to Patients With Systemic Autoimmune Rheumatic Diseases
10/31/2025
Grace Taylor, MS, MA
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune rheumatic diseases face high hospitalization rates from RSV, according to study published in Seminars in Arthritis and Rheumatism.
Patients with autoimmune...
10/31/2025
Pharmacy Learning Network
News
Dual RSV and Influenza Vaccination Reduces Health Care Utilization and Costs Among Older Adults
10/31/2025
Juliet Gallagher
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study using the Humana Healthcare Research database highlights the significant clinical and economic benefits of respiratory syncytial virus (RSV) vaccination among older adults in the US.
A new retrospective cohort study...
10/31/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Proves Highly Effective Against Severe RSV in Older Adults
10/29/2025
Grace Taylor, MS, MA
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser Permanente Southern California shows that Pfizer’s RSVpreF vaccine provides strong protection against severe respiratory syncytial virus (RSV)–related illness and hospitalizations in older adults, including...
A real-world study led by Kaiser...
10/29/2025
Pharmacy Learning Network
News
RSV Poses Sixfold Higher Hospitalization and Death Risk for Long-Term Care Residents
10/21/2025
Lisa Kuhns, PhD, MD
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term care facilities face a dramatically higher risk of severe illness and death from respiratory syncytial virus (RSV) than their community-dwelling peers, according to new data published in The Journal of the...
Older adults living in long-term...
10/21/2025
Pharmacy Learning Network
News
RSV Vaccines Cut Hospitalizations in Older Adults but Show Gaps in High-Risk Groups
09/29/2025
Grace Taylor, MS, MA
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds respiratory syncytial virus (RSV) vaccines significantly reduce hospitalizations in adults 60 and older, though protection wanes over time and is weaker in immunocompromised patients and those with cardiovascular...
A new 2-season study finds...
09/29/2025
Pharmacy Learning Network
News
RSV Pneumonia Leads to Elevated ICU Admissions and Mortality in Older Adults
08/08/2025
Grace Taylor, MS, MA
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus (RSV) pneumonia leads to high intensive care unit (ICU) admission and mortality rates in older adults, rivaling those of influenza and human metapneumovirus, according to a study published in the Journal of...
Respiratory syncytial virus...
08/08/2025
Pharmacy Learning Network
PharmLaw
PBM Trade Group Challenges Illinois Drug Pricing Transparency Law on ERISA Grounds
06/24/2026
Hannah Musick
The Pharmaceutical Care Management Association has sued Illinois to block key provisions of the state's Prescription Drug Affordability Act, setting up a legal challenge that could shape the future of pharmacy benefit manager (PBM)...
The Pharmaceutical Care Management Association has sued Illinois to block key provisions of the state's Prescription Drug Affordability Act, setting up a legal challenge that could shape the future of pharmacy benefit manager (PBM)...
The Pharmaceutical Care...
06/24/2026
Pharmacy Learning Network
News
Primidone Tablets Recalled Due to Cross Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug Administration (FDA) has issued a Class III recall for primidone tablets for cross contamination with other products, affecting 27 936 bottles.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Alcohol Sanitizer Spray Recalled Due to Microbial Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug Administration (FDA) has issued a Class II recall for alcohol sanitizer spray due to microbial contamination, affecting 5 drums.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
News
Doxorubicin Hydrochloride Liposome Injections Recalled Due to Foreign Contamination
06/17/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug Administration (FDA) has issued a Class I recall for doxorubicin hydrochloride liposome injection due to the presence of particulate matter, affecting 675 vials.
The US Food and Drug...
06/17/2026
Pharmacy Learning Network
PharmLaw
Ahold Delhaize USA to Pay $40 Million in Drug Price Claims Settlement
06/16/2026
Grace Taylor, MS, MA
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay...
06/16/2026
Pharmacy Learning Network
PharmLaw
Federal Court Grants Lilly Preliminary Injunction in $200 Million Drug Rebate Fraud Case
06/11/2026
Hannah Musick
A federal court has granted Eli Lilly a preliminary injunction in its lawsuit alleging a $200 million rebate fraud scheme involving Trulicity, requiring defendants to provide detailed documentation for future rebate claims and signaling...
A federal court has granted Eli Lilly a preliminary injunction in its lawsuit alleging a $200 million rebate fraud scheme involving Trulicity, requiring defendants to provide detailed documentation for future rebate claims and signaling...
A federal court has granted Eli...
06/11/2026
Pharmacy Learning Network
News
Duloxetine Delayed Release Capsules Recalled Due to CGMP Deviations
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for duloxetine delayed release capsules for Current Good Manufacturing Practice (CGMP) deviations, affecting 50 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
Extra Strength Antacid Calcium Carbonate Recalled Due to Foreign Contamination
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug Administration (FDA) has issued a Class II recall for extra strength antacid calcium carbonate due to the presence of metallic particles in the product.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
Amlodipine and Olmesartan Medoxomil Tablets Recalled Due to Failure to Meet Dissolution Specifications
06/11/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug Administration (FDA) has issued a Class II recall for amlodipine and olmesartan medoxomil tablets due to failed dissolution specifications, affecting 15 696 bottles.
The US Food and Drug...
06/11/2026
Pharmacy Learning Network
News
MG217 Treatment Cream and Skin Protectant Recalled Due to Staphylococcus Aureus Contamination
06/04/2026
Rebecca Amrick
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug Administration (FDA) has issued a Class I recall for MG217 multisymptom treatment cream and skin protectant due to microbial contamination of staphylococcus aureus, affecting 690 tubes.
The US Food and Drug...
06/04/2026
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use